by Wouter Hendrickx | May 17, 2021 | Life Sciences, News
The University of Antwerp, the University Hospital of Antwerp and Verhaert Masters in Innovation team up once again in 2021 to boost medical innovation in Flanders. This year the City of Antwerp is joining the Medical Solutions Accelerator. Together they will help...
by Wouter Hendrickx | May 10, 2021 | Life Sciences, Product innovation, Webinars
Valorizing academic medical technology is not a walk in the park. You have to take into account an organization that envisions multiple avenues, from pre-incubation, facilitation and creation of start-ups, start-up funding to industrial collaboration. Find out in the...
by Tess Loete | Dec 10, 2020 | Life Sciences, News
On 4 December, the first edition of the acceleration program Medical Solutions Accelerator finished with a pitch moment. In this final event, the jury selected the most promising start-up for a follow-up trajectory. Start-ups pitch innovative solutions during jury...
by Frederik Aldelhof | Nov 23, 2020 | Digital innovation, Life Sciences, Perspectives
Successful medical app development projects clearly benefit from defining a robust architecture and a comprehensive strategic vision and framework. They also acknowledge the importance of user validation and behavioral design, even when Covid-19 is added to the...
by Wouter Hendrickx | Nov 13, 2020 | Digital innovation, Life Sciences, Webinars
Health services are becoming more and more home based. This transformation isn’t driven by technology, but by user and business motives. It personalizes and improves overall care and reduces treatment cost and time. Find out more in this lecture from Frederik Mortier,...
by David Pas | Nov 13, 2020 | Life Sciences, Product innovation, Strategic innovation, Webinars
The innovation speed has become so high that human adoption has become the bottleneck. To overcome this challenge you need to identify reasons for rejection and adoption, and intentionally redesign physical experiences to affect user behavior. Find out more on...
